Cost-effectiveness of drotrecogin alfa (activated) for the treatment of severe sepsis: A cross-national comparison of three European countries
2002 | conference abstract. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Cost-effectiveness of drotrecogin alfa (activated) for the treatment of severe sepsis: A cross-national comparison of three European countries
Neilson, A.; Schneider, H.; Burchardi, H.; Chinn, C.; Clouth, J. & Graebe, A. (2002)
Value in Health, 5(6)
Malden: Blackwell Publishing Inc. DOI: https://doi.org/10.1016/S1098-3015(10)61483-0
